InvestorsHub Logo
Post# of 486
Next 10
Followers 85
Posts 5198
Boards Moderated 1
Alias Born 01/23/2010

Re: JnNider post# 185

Saturday, 06/16/2018 4:39:58 PM

Saturday, June 16, 2018 4:39:58 PM

Post# of 486
Well, so far Google and everybody else has failed at it. The point is, InWith has the technology right now. Any tech to come along that somehow finds a way around it is years away, if at all. As for the elastic circuit patent, it has enough in it to own the market on being able to mass produce silicon hydrogel contact lenses that have embedded circuitry.

Then you look at the details of InWith's 3 other patents and the plethora of those in the process of being reviewed, with 1st to file' status, its going to be an interesting path forward.

After personally talking with Silicon Valley patent lawyer heavyweights, WSGR, they are extremely excited about InWith's patent portfolio. Especially, the elastic circuit patent. The hour or so that I got to sit down with them and hear whats going on in the industry, who wants to be a player, etc, that pretty much puts to rest any skepticism I had or hear from those that aren't on the same level as the industry professionals that are actually working in this field.

Everything known to man, when it comes to technology, has a question mark around it. InWith has plenty as does every single company out there. The cards with this company will fall where they fall. Same with J&J, Samsung, Google, and the plethora of small companies out there trying nudge their way into this arena of smart contact lenses. Its going to be an exciting industry to follow.

InWith has stated their first prototype, built with a specific function for a specific biotech, is due to be complete this year. Will be interesting to learn what the function will be and with whom. If its a success, then they can start the clock, 2 years'ish, for the time to conduct trials, etc, to get the product to market.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.